Alkeran and Asthma aggravated - a phase IV clinical study of FDA data

Summary:

Asthma aggravated is reported as a side effect among people who take Alkeran (melphalan), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Zometa, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Asthma aggravated when taking Alkeran. It is created by eHealthMe based on reports of 5,418 people who have side effects when taking Alkeran from the FDA, and is updated regularly.

What is Alkeran?

Alkeran has active ingredients of melphalan. eHealthMe is studying from 5,429 Alkeran users. Check the latest studies of Alkeran.

What is Asthma aggravated?

Asthma aggravated is found to be associated with 1,813 drugs and 641 conditions by eHealthMe. Check the latest studies of Asthma aggravated.

On Aug, 08, 2026

5,418 people reported to have side effects when taking Alkeran.
Among them, 42 people (0.78%) have Asthma aggravated.

Among these 42 people:

How long have people been on Alkeran when they have Asthma aggravated? *

What is the gender of people who have Asthma aggravated when taking Alkeran? *

female: 46.34 %
male: 53.66 %

What is the age of people who have Asthma aggravated when taking Alkeran? *

What are other drugs people take besides Alkeran? *

What are other side effects people have besides Asthma aggravated? *

Constipation: 34 people, 80.95%
Osteonecrosis Of Jaw (death of bone of jaw): 34 people, 80.95%
Stress And Anxiety: 34 people, 80.95%
Pain: 34 people, 80.95%
Back Pain: 33 people, 78.57%
Acute Kidney Failure: 32 people, 76.19%
Pneumonia: 32 people, 76.19%
Hypokalemia (low potassium): 32 people, 76.19%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 31 people, 73.81%
Dyspnea (difficult or laboured breathing): 31 people, 73.81%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 13 people, 30.95%
Osteoporosis (bones weak and more likely to break): 2 people, 4.76%
Ill-Defined Disorder: 2 people, 4.76%
Type 2 Diabetes: 1 person, 2.38%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 2.38%
Bone Disorder: 1 person, 2.38%
Bone Marrow Conditioning Regimen: 1 person, 2.38%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 1 person, 2.38%
Colon Cancer: 1 person, 2.38%
Crying: 1 person, 2.38%

* Approximation only. Some reports may have incomplete information.

Do you take Alkeran and have Asthma aggravated?

- Check whether Asthma aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Alkeran:

Alkeran (5,429 reports)

Browse all side effects of Alkeran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Asthma aggravated:

Asthma aggravated (1,814 drugs)

Browse all the conditions that are associated with Asthma aggravated:

Asthma aggravated (641 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on melphalan (the active ingredients of Alkeran) and Alkeran (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.